abt – Page 5 – Scalper1

Abbott Q1 Performance Slips, But EPS Tops Estimates

Abbott Laboratories’ (ABT) first-quarter revenue and earnings dipped, but earnings still topped analyst estimates, sending shares slightly higher Wednesday. The medical products giant reported a 2.4% fall in earnings to 41 cents per share. But this still topped the 36 cents per share analysts polled by Thomson Reuters were expecting. Revenue dipped 2.5% to $5.24 billion, slightly less than views for $5.27 billion. Global sales fell 0.5% on an

Abbott Labs Q4 Sales Miss Estimates; Earnings In Line

Medical products giant Abbott Laboratories (ABT) missed Q4 sales estimates while meeting profit expectations Wednesday, sending Abbott stock down 2% in morning trading on the stock market today. Earlier it had been down as much as 5.6%. Abbott said revenue totaled $5.66 billion in the quarter, up 0.4% from the year-earlier quarter and about $60 million short of analysts’ consensus. Earnings rose 21% to 58 cents a share, matching estimates. The